Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Pulmonary Hypertension, January 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 181 articles:
HTML format


 

Single Articles

  1. BADAGLIACCA R, Ghio S, Manzi G, Vizza CD, et al
    Right Ventricular/Pulmonary Artery Coupling in Patients With Heart Failure With Preserved Ejection Fraction: A Clue for Pulmonary Hypertension?
    J Am Heart Assoc. 2023 Dec 29:e032639. doi: 10.1161/JAHA.123.032639.
    PubMed    


  2. CHEN ZW, Chung YW, Cheng JF, Huang CY, et al
    Right Ventricular-Vascular Uncoupling Predicts Pulmonary Hypertension in Clinically Diagnosed Heart Failure With Preserved Ejection Fraction.
    J Am Heart Assoc. 2023 Dec 29:e030025. doi: 10.1161/JAHA.123.030025.
    PubMed    
    Abstract available

  3. HE Z, Zhang D, Wang X
    Fibrosing mediastinitis manifesting as refractory pleural effusion and severe pulmonary hypertension successfully treated by percutaneous pulmonary vein stenting.
    Eur Heart J. 2023 Dec 28:ehad862. doi: 10.1093.
    PubMed    


  4. KLEINNIBBELINK G, Buckley BJR, Harrison SL, Williams N, et al
    Exercised-based cardiac rehabilitation associates with lower all-cause mortality in patients with primary pulmonary hypertension.
    Front Sports Act Living. 2023;5:1247615.
    PubMed    
    Abstract available

  5. WILLIAMS EE, Bednarczuk N, Nanjundappa M, Greenough A, et al
    Monitoring persistent pulmonary hypertension of the newborn using the arterial to end tidal carbon dioxide gradient.
    J Clin Monit Comput. 2023 Dec 27. doi: 10.1007/s10877-023-01105.
    PubMed    
    Abstract available

  6. STUBBS H, Lua S, Ingram J, Jani BD, et al
    Remote exercise testing in pulmonary hypertension (PHRET).
    Pulm Circ. 2023;13:e12325.
    PubMed    
    Abstract available

  7. KAVGACI A, Tunaoglu FS, Kula S, Oguz AD, et al
    Early Echocardiographic Findings of Pulmonary Hypertension-specific Therapy in Children.
    Medeni Med J. 2023;38:268-275.
    PubMed    
    Abstract available

  8. LAN C, Fang G, Qiu C, Li X, et al
    Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3/Pim-1/NFAT pathway.
    Clin Exp Hypertens. 2024;46:2297642.
    PubMed    
    Abstract available

  9. LONE AM, Kanthimathinathan HK
    Milrinone in pediatric heart failure and pulmonary hypertension: Is meta-analyses the answer?
    Eur J Pediatr. 2023 Dec 26. doi: 10.1007/s00431-023-05402.
    PubMed    


  10. HAFNER F, Johansson C, Schwarzkopf L, Forster K, et al
    Current diagnosis and treatment practice for pulmonary hypertension in bronchopulmonary dysplasia-A survey study in Germany (PUsH BPD).
    Pulm Circ. 2023;13:e12320.
    PubMed    
    Abstract available

  11. MORLAND K, Gerges C, Elwing J, Visovatti SH, et al
    Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Grou
    Pulm Circ. 2023;13:e12317.
    PubMed    
    Abstract available

  12. SYNN AJ, Harder EM, Nardelli P, Ross JC, et al
    Automated CT-Based Quantification of Pulmonary Veins Shows Greater Central Venous Dilation in Group 2 Pulmonary Hypertension Compared With Group 1 Pulmonary Arterial Hypertension and Control Subjects.
    CHEST Pulm. 2023;1:100020.
    PubMed    


  13. SUZUKI Y, Nagaoka T, Terayama Y, Nagata Y, et al
    Prognostic analysis of pulmonary hypertension with lung parenchymal lesion: Comparison of mortality with and without connective tissue disease.
    Respir Investig. 2023;62:167-175.
    PubMed    
    Abstract available

  14. YEGAMBARAM M, Sun X, Flores AG, Lu Q, et al
    Novel Relationship between Mitofusin 2-Mediated Mitochondrial Hyperfusion, Metabolic Remodeling, and Glycolysis in Pulmonary Arterial Endothelial Cells.
    Int J Mol Sci. 2023;24:17533.
    PubMed    
    Abstract available

  15. PAPAVASSILIOU KA, Gogou VA, Papavassiliou AG
    Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies.
    Int J Mol Sci. 2023;24:17441.
    PubMed    
    Abstract available

  16. TOPYLA-PUTOWSKA W, Tomaszewski M, Wojtkowska A, Wysokinski A, et al
    Novel Echocardiographic Measurements of Right Ventricular-Pulmonary Artery Coupling in Predicting the Prognosis of Precapillary Pulmonary Hypertension.
    J Pers Med. 2023;13:1627.
    PubMed    
    Abstract available

  17. PILKA M, Darocha S, Florczyk M, Manczak R, et al
    The Utility of a Resting Electrocardiogram (ECG-PH Index) in Evaluating the Efficacy of Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.
    J Clin Med. 2023;12:7621.
    PubMed    
    Abstract available

  18. KUROPATKINA T, Atiakshin D, Sychev F, Artemieva M, et al
    Hydrogen Inhalation Reduces Lung Inflammation and Blood Pressure in the Experimental Model of Pulmonary Hypertension in Rats.
    Biomedicines. 2023;11:3141.
    PubMed    
    Abstract available

  19. YAN S, Sheak JR, Walker BR, Jernigan NL, et al
    Contribution of Mitochondrial Reactive Oxygen Species to Chronic Hypoxia-Induced Pulmonary Hypertension.
    Antioxidants (Basel). 2023;12:2060.
    PubMed    
    Abstract available

  20. LUN X, Yang J, Liu Y, Zhao F, et al
    Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
    Medicine (Baltimore). 2023;102:e36654.
    PubMed    
    Abstract available

  21. ELKHAPERY A, Hammami MB, Sulica R, Boppana H, et al
    Pulmonary Vasodilator Therapy in Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (Severe PH-COPD): A Systematic Review and Meta-Analysis.
    J Cardiovasc Dev Dis. 2023;10:498.
    PubMed    
    Abstract available

  22. HOPKINS CD, Wessel C, Chen O, El-Kersh K, et al
    A hypothesis: Potential contributions of metals to the pathogenesis of pulmonary artery hypertension.
    Life Sci. 2024;336:122289.
    PubMed    
    Abstract available

  23. XIONG J, Peng Y, Li J, Cai S, et al
    Total iron binding capacity: an independent predictor of prognosis for pulmonary arterial hypertension in systemic lupus erythematosus.
    Scand J Rheumatol. 2024;53:44-48.
    PubMed    
    Abstract available

  24. NANDI D, Kumar S, Singh R
    Does Bronchial Artery Hypertrophies After Descending Thoracic Aorta Stenting in Takayasu Arteritis? - A Clinical Dilemma.
    Vasc Endovascular Surg. 2024;58:218-222.
    PubMed    
    Abstract available


  25. Pulmonary hypertension.
    Nat Rev Dis Primers. 2024;10:2.
    PubMed    


  26. MOCUMBI A, Humbert M, Saxena A, Jing ZC, et al
    Pulmonary hypertension.
    Nat Rev Dis Primers. 2024;10:1.
    PubMed    
    Abstract available

  27. DONG R, Liang Y, Ni M, Wang D, et al
    Electrocardiogram Parameters Associated With the Diagnosis of Pulmonary Hypertension in High-Altitude Tibetan Populations: A Retrospective Single-Centre Study.
    Heart Lung Circ. 2024 Jan 3:S1443-9506(23)04418.
    PubMed    
    Abstract available

  28. TANG C, Shi F, Ji Y, Zhu J, et al
    Aldehyde Dehydrogenase 2 (ALDH2) rs671 Polymorphism is a Predictor of Pulmonary Hypertension Due to Left Heart Disease.
    Heart Lung Circ. 2024 Jan 4:S1443-9506(23)04446.
    PubMed    
    Abstract available

  29. KIELY DG, Hamilton N, Wood S, Durrington C, et al
    Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service.
    BMJ Open. 2024;14:e080068.
    PubMed    
    Abstract available

  30. LIU M, Wang X, Yan Z, Wang Z, et al
    Network Analysis on Family Resilience, Fear of Progression, and Quality of Life in Chinese Patients with Pulmonary Hypertension.
    Heart Lung. 2024;64:128-136.
    PubMed    
    Abstract available

  31. HUANG YZ, Wu JC, Lu GF, Li HB, et al
    Pulmonary Hypertension Induces Serotonin Hyperreactivity and Metabolic Reprogramming in Coronary Arteries via NOX1/4-TRPM2 Signaling Pathway.
    Hypertension. 2024 Jan 4. doi: 10.1161/HYPERTENSIONAHA.123.21345.
    PubMed    
    Abstract available

  32. NATHAN SD, Tehrani B, Zhao Q, Arias R, et al
    Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis.
    Pulm Circ. 2024;14:e12311.
    PubMed    
    Abstract available

  33. SATAWIRIYA M, Khongphatthanayothin A, Limsuwan A
    Reversible severe pulmonary hypertension related to scurvy in children.
    BMC Cardiovasc Disord. 2024;24:24.
    PubMed    
    Abstract available

  34. WAN JJ, Yi J, Wang FY, Zhang C, et al
    Expression and regulation of HIF-1a in hypoxic pulmonary hypertension: Focus on pathological mechanism and Pharmacological Treatment.
    Int J Med Sci. 2024;21:45-60.
    PubMed    
    Abstract available

  35. WANG J, Liu J, Tao X, Xie W, et al
    Safety and efficacy of balloon pulmonary angioplasty for technically operable chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2023;14:e12327.
    PubMed    
    Abstract available

  36. YE T, Song Z, Zhou Y, Liu Z, et al
    TRPV2 inhibitor tranilast prevents atrial fibrillation in rat models of pulmonary hypertension.
    Cell Calcium. 2023;117:102840.
    PubMed    
    Abstract available

  37. UMETANI K, Atsumi M
    Haemodialysis patient with chronic kidney disease and pulmonary hypertension treated effectively with pulmonary vasodilators.
    BMJ Case Rep. 2023;16:e255810.
    PubMed    
    Abstract available

  38. TALWAR S, Gangoor N, Maldar SB, Pinto CJ, et al
    Isolated unilateral pulmonary artery atresia in an adult presenting with cor pulmonale.
    BMJ Case Rep. 2023;16:e256663.
    PubMed    
    Abstract available

  39. SHARIYA AM, Martynyuk TV, Shariya MA, Ustyuzhanin DV, et al
    [Applying of magnetic resonance tomography for assessment of cardiac remodeling and risk stratification in patients with pulmonary arterial hypertension].
    Ter Arkh. 2023;95:291-295.
    PubMed    
    Abstract available

  40. CHAZOVA IE
    [Chronic thromboembolic pulmonary hypertension: current diagnostic and treatment options: A review].
    Ter Arkh. 2023;95:1017-1021.
    PubMed    
    Abstract available

  41. GAO AL, Gong JN, Li JF, Yang YH, et al
    [A case of heritable pulmonary arterial hypertension treated with long-term oral low-dose imatinib].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:36-38.
    PubMed    
    Abstract available

  42. TRAMMELL AW, Hart CM
    LKB1 Regulates Pulmonary Hypertension Endothelial Cell Mitochondria: Another Layer of the Pulmonary Vascular Onion?
    Am J Respir Cell Mol Biol. 2024;70:5-7.
    PubMed    


  43. CALLISTO A, Hansen D, Walker J, Ngian GS, et al
    Impact of the COVID-19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis.
    Arthritis Care Res (Hoboken). 2024;76:81-87.
    PubMed    
    Abstract available

  44. LENTINE KL, Levine DJ, Runo JR, Caliskan Y, et al
    Complexities and outcomes of pulmonary hypertension in kidney transplant patients: a comprehensive review.
    Turkish J Nephrol. 2024;33:8-26.
    PubMed    
    Abstract available

  45. IVANOV B, Krasivskyi I, Forster F, Gaisendrees C, et al
    Impact of pulmonary hypertension on short-term outcomes in patients undergoing surgical aortic valve replacement for severe aortic valve stenosis.
    Perfusion. 2024 Jan 11:2676591241227883. doi: 10.1177/02676591241227883.
    PubMed    
    Abstract available

  46. OUELLET S, Drolet C, Morissette G, Pellerin A, et al
    Vasopressin in newborns with refractory acute pulmonary hypertension.
    Pediatr Res. 2024 Jan 11. doi: 10.1038/s41390-023-02995.
    PubMed    
    Abstract available

  47. YANG Y, Li X, Wang P, Shu S, et al
    The significance of dynamic monitoring plasma TMAO level in pulmonary arterial hypertension - a cohort study.
    Ther Adv Respir Dis. 2024;18:17534666231224692.
    PubMed    
    Abstract available

  48. SINGHI AK, Mohapatra SK, Biswas N, Bandyopadhyay KH, et al
    PULMOEAST: A Comprehensive Analysis of Pulmonary Hypertension in Eastern India.
    Cureus. 2023;15:e50996.
    PubMed    
    Abstract available

  49. SHLOBIN OA, Shen E, Wort SJ, Piccari L, et al
    Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.
    Pulm Circ. 2024;14:e12310.
    PubMed    
    Abstract available

  50. DESAI R, Gandhi Z, Shiza ST, Jain A, et al
    Prevalence and impact of tobacco use disorder on in-hospital mortality in patients hospitalized with non-group 1 pulmonary hypertension: a nationwide propensity score-matched analysis, 2019.
    EXCLI J. 2023;22:1200-1210.
    PubMed    
    Abstract available

  51. D'AGOSTINO A, Lanzafame LG, Buono L, Crisci G, et al
    Modulating NO-GC Pathway in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2023;25:36.
    PubMed    
    Abstract available

  52. CONTRERAS J, Nussbaum J, Cangialosi P, Thapi S, et al
    Pulmonary Hypertension in Underrepresented Minorities: A Narrative Review.
    J Clin Med. 2024;13:285.
    PubMed    
    Abstract available

  53. MATOS JI, Garcia-Rodriguez SN, Costa-Rodriguez N, Caro-Vadillo A, et al
    Right Ventricle Strain Assessed by 2-Dimensional Speckle Tracking Echocardiography (2D-STE) to Evaluate Pulmonary Hypertension in Dogs with Dirofilaria immitis.
    Animals (Basel). 2023;14:26.
    PubMed    
    Abstract available

  54. ZHANG A, Ding L, Zhang H, Mi L, et al
    Radiofrequency catheter ablation for pulmonary hypertension patients with atrial flutter.
    ESC Heart Fail. 2024 Jan 10. doi: 10.1002/ehf2.14659.
    PubMed    
    Abstract available

  55. YU X, Qin W, Cai H, Ren C, et al
    Analyzing the molecular mechanism of xuefuzhuyu decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking.
    Comput Biol Med. 2023;169:107863.
    PubMed    
    Abstract available

  56. TAI YY, Yu Q, Tang Y, Sun W, et al
    Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension.
    Sci Transl Med. 2024;16:eadd2029.
    PubMed    
    Abstract available

  57. ZHANG J, Xu C, Tang X, Sun S, et al
    Endothelium-specific SIRT7 targeting ameliorates pulmonary hypertension through KLF4 deacetylation.
    Cardiovasc Res. 2024 Jan 10:cvae011. doi: 10.1093.
    PubMed    
    Abstract available

  58. RAJKUMAR S, Jha AK, Parida S, Thangaswamy CR, et al
    Effect of Acute Vasodilator Testing Using Oxygen in Pulmonary Hypertension Due to Left Heart Disease.
    Semin Cardiothorac Vasc Anesth. 2024 Jan 10:10892532241227082.
    PubMed    
    Abstract available

  59. HUANG J, Zhang W, Fu W, Le J, et al
    Noninvasive evaluation of pulmonary hypertension using the second heart sound parameters collected by a mobile cardiac acoustic monitoring system.
    Front Cardiovasc Med. 2023;10:1292647.
    PubMed    
    Abstract available

  60. ALVAREZ TRONCOSO J, Soto Abanades C, Robles-Marhuenda A, Alcolea Batres S, et al
    Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol.
    RMD Open. 2024;10:e003674.
    PubMed    
    Abstract available

  61. BRITO J, Pinto FJ, Placido R
    Chronic fibrothrombotic deposits: a cause or consequence of pulmonary hypertension?
    Rev Esp Cardiol (Engl Ed). 2024 Jan 6:S1885-5857(24)00015.
    PubMed    


  62. SCHULZE KM, Horn AG, Weber RE, Behnke BJ, et al
    Pulmonary hypertension alters blood flow distribution and impairs the hyperemic response in the rat diaphragm.
    Front Physiol. 2023;14:1281715.
    PubMed    
    Abstract available

  63. ABDEEN AMZ, Alagha Z, Clark C, Al-Astal A, et al
    Paradoxical Worsening of Pulmonary Hypertension Following Closure of Arteriovenous Fistula: A Case Report and Literature Review.
    Cureus. 2023;15:e50064.
    PubMed    
    Abstract available

  64. SONAGLIONI A, Nicolosi GL, Rispoli GA, Lombardo M, et al
    Incidental Finding of Lipomatous Hypertrophy of the Right Atrial Free Wall in an Elderly Female With Severe Pulmonary Hypertension: Early Detection by Multimodality Imaging.
    Cureus. 2023;15:e50665.
    PubMed    
    Abstract available

  65. ZHENG SW, Wang Z, Zhai ZG, Sun YH, et al
    [Progresses in pulmonary hypertension associated with left-sided heart failure].
    Zhonghua Nei Ke Za Zhi. 2024;63:113-120.
    PubMed    


  66. ULRICH A, Wu Y, Draisma H, Wharton J, et al
    Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension.
    Nat Commun. 2024;15:330.
    PubMed    
    Abstract available

  67. SALAZAR AM, Panama G, Kim AG, Rayamajhi S, et al
    Clinical outcomes between direct oral anticoagulants versus vitamin K antagonists in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
    Curr Probl Cardiol. 2024;49:102377.
    PubMed    
    Abstract available

  68. TOMITA S, Nakanishi N, Ogata T, Higuchi Y, et al
    The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding.
    Commun Biol. 2024;7:40.
    PubMed    
    Abstract available

  69. GUPTA S, Mohta A, Thameem D
    Vasoreactive pulmonary artery hypertension in non-fibrotic hypersensitive pneumonitis.
    BMJ Case Rep. 2024;17:e255921.
    PubMed    
    Abstract available

  70. DONG S, Guo X, Wang H, Sun C, et al
    Liver injury due to endothelin receptor antagonists: a real-world study based on post-marketing drug monitoring data.
    Ther Adv Respir Dis. 2024;18:17534666231223606.
    PubMed    
    Abstract available

  71. DE BIE FR, Regin Y, Dubois A, Scuglia M, et al
    Prenatal treprostinil improves pulmonary arteriolar hypermuscularization in the rabbit model of congenital diaphragmatic hernia.
    Biomed Pharmacother. 2024;170:115996.
    PubMed    
    Abstract available

  72. AKSOY A, Kocakaya D, Demircioglu O, Cimsit NC, et al
    Angiographic findings of pulmonary arterial involvement in Behcet's Disease: Do they correlate with symptoms and acute phase response?
    Respir Med. 2024;221:107481.
    PubMed    
    Abstract available

  73. CHE Y, Xia T, Liu H, Li C, et al
    Preparation of betaine injection and its therapeutic effect in pulmonary arterial hypertension.
    Basic Clin Pharmacol Toxicol. 2024;134:219-230.
    PubMed    
    Abstract available

  74. HUANG Z, Duan A, Zhao Z, Zhao Q, et al
    Sleep-disordered breathing patterns and prognosis in pulmonary arterial hypertension: A cluster analysis of nocturnal cardiorespiratory signals.
    Sleep Med. 2024;113:61-69.
    PubMed    
    Abstract available

  75. SZABARI MV, Ni C, Davila D, Viragh K, et al
    Pulmonary Arterial Tumor Embolism From Recurrent Metastatic Renal Cell Carcinoma on FDG PET/CT.
    Clin Nucl Med. 2023 Nov 17. doi: 10.1097/RLU.0000000000004956.
    PubMed    
    Abstract available

  76. SALAHUDDIN M, Shahid S, Tariq U, Aqeel M, et al
    Outcomes of patients with elevated pulmonary artery systolic pressure on echocardiography due to chronic lung diseases.
    Respir Investig. 2024;62:69-74.
    PubMed    
    Abstract available

  77. KULARATNE M, Boucly A, Savale L, Solinas S, et al
    Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension.
    Expert Opin Pharmacother. 2023;24:2101-2115.
    PubMed    
    Abstract available

  78. MANSOOR M, Shahid S, Tariq S, Aziz A, et al
    Letter to Editor: Prevalence and Determinants of Delay in Time-to-Diagnosis for Pulmonary Arterial Hypertension (PAH) Patients in Gansu China: An Observational Cohort Study.
    Curr Probl Cardiol. 2024;49:102133.
    PubMed    


  79. BZDEGA K, Biela M, Deutsch GH, Kitzmiller JA, et al
    A novel non-recurrent CNV deletion involving TBX4 and leaving TBX2 intact causes congenital alveolar dysplasia.
    Clin Genet. 2024;105:190-195.
    PubMed    
    Abstract available

  80. HUO X, Zeng Z, Lin Y, Lin J, et al
    Clinical characteristics of systemic sclerosis patients with occupational silicosis.
    Clin Rheumatol. 2024;43:277-287.
    PubMed    
    Abstract available

  81. TOWER DR, Day RW, Marrone T, Palmquist R, et al
    Rapid genome diagnosis of alveolar capillary dysplasia leading to treatment in a child with respiratory and cardiac failure.
    Cold Spring Harb Mol Case Stud. 2024;9:a006292.
    PubMed    
    Abstract available

  82. TOSHIMA T, Rhu J, Yoon YI, Ito T, et al
    Aborted living-donor liver transplantation in the real-world setting, lessons from 13 937 cases of Vanguard Multi-center Study of International Living Donor Liver Transplantation Group.
    Am J Transplant. 2024;24:57-69.
    PubMed    
    Abstract available

  83. LAI Y, Chen M, Chen M, Li C, et al
    Gender differences in the incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: A meta-analysis.
    Medicine (Baltimore). 2024;103:e35150.
    PubMed    
    Abstract available

  84. SANTAMANS AM, Cicuendez B, Mora A, Villalba-Orero M, et al
    MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension.
    Sci Adv. 2024;10:eadk6524.
    PubMed    
    Abstract available

  85. ZANOTTO TM, Goncalves AESS, Saad MJA
    Pulmonary hypertension and insulin resistance: a mechanistic overview.
    Front Endocrinol (Lausanne). 2024;14:1283233.
    PubMed    
    Abstract available

  86. JIN J, Rothamel P, Buchel J, Kammer B, et al
    Case Report: Stuve-Wiedemann syndrome-a rare cause of persistent pulmonary hypertension of the newborn.
    Front Pediatr. 2024;11:1329404.
    PubMed    
    Abstract available

  87. WARNER ED, Corsi DR, Jimenez D, Bierowski M, et al
    Determinants of Pulmonary Hypertension in Patients with End-stage Kidney Disease and Arteriovenous Access.
    Curr Probl Cardiol. 2024 Jan 16:102406. doi: 10.1016/j.cpcardiol.2024.102406.
    PubMed    
    Abstract available

  88. YAGHOOBI N, Maghsudi M, Malek H, Bakhshandeh H, et al
    Role of CT attenuation correction gated SPECT MPI in prediction of pulmonary hypertension.
    J Nucl Cardiol. 2023;31:101777.
    PubMed    
    Abstract available

  89. LI S, Lyu Q, Shi Q, Bai Y, et al
    Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4/H2O2/PPAR-gamma axis.
    Clin Sci (Lond). 2024 Jan 18:CS20231508. doi: 10.1042/CS20231508.
    PubMed    
    Abstract available

  90. KONG L, Lv M, Qiao CL, Sun XX, et al
    The effect of pituitrin on postoperative outcomes in patients with pulmonary hypertension undergoing cardiac surgery: a study protocol for a randomized controlled trial.
    Front Cardiovasc Med. 2024;10:1269624.
    PubMed    
    Abstract available

  91. HUANG J, Zhu H, Liu S, Li M, et al
    Protein profiling in systemic sclerosis patients with different pulmonary complications using proteomic antibody microarray.
    Arthritis Res Ther. 2024;26:29.
    PubMed    
    Abstract available

  92. MOCUMBI A, Humbert M, Saxena A, Jing ZC, et al
    Publisher Correction: Pulmonary hypertension.
    Nat Rev Dis Primers. 2024;10:5.
    PubMed    


  93. VAN HEERDEN JK, Louw EH, Thienemann F, Engel ME, et al
    The prevalence of pulmonary hypertension in post-tuberculosis and active tuberculosis populations: a systematic review and meta-analysis.
    Eur Respir Rev. 2024;33:230154.
    PubMed    
    Abstract available

  94. LECHARTIER B, Boucly A, Solinas S, Gopalan D, et al
    Pulmonary veno-occlusive disease: illustrative cases and literature review.
    Eur Respir Rev. 2024;33:230156.
    PubMed    
    Abstract available

  95. ZAROGOULIDIS P, Petridis D, Huang H, Bai C, et al
    Nebulisation of Paclitaxel, Sotatercept and Iloprost for pulmonary hypertension for lung cancer. From In vitro to In vivo.
    J Cancer. 2024;15:871-879.
    PubMed    
    Abstract available

  96. YANG Y, Xu J, Shu S, Wang P, et al
    Circulating acetylcholine serves as a potential biomarker role in pulmonary hypertension.
    BMC Pulm Med. 2024;24:35.
    PubMed    
    Abstract available

  97. HSIAO CY, Lu WH
    Effective control of refractory pulmonary hypertension with iloprost inhalation in an infant with congenital absence of the right pulmonary artery: a case report.
    Cardiol Young. 2024 Jan 15:1-4. doi: 10.1017/S104795112300450.
    PubMed    
    Abstract available

  98. ZHANG Y, Zhang Y, Liao C, Wang X, et al
    Prognostic implication of glomerular filtration rates in patients with chronic thromboembolic pulmonary hypertension who have undergone balloon pulmonary angioplasty.
    Exp Ther Med. 2023;27:18.
    PubMed    
    Abstract available

  99. FERNICOLA F, Carli A, Arienti F, Viola Vasarri M, et al
    Fatal severe persistent pulmonary hypertension with lung microvasculature parietal hyperplasia in a neonate with congenital cytomegalovirus infection treated in-utero with valacyclovir: A case report.
    Eur J Obstet Gynecol Reprod Biol. 2024 Jan 11:S0301-2115(24)00011.
    PubMed    


  100. CHOI R, Narayanan R, Jandu S, Savage W, et al
    Optimization of resting tension for wire myography in male rat pulmonary arteries.
    Physiol Rep. 2024;12:e15911.
    PubMed    
    Abstract available

  101. HUYNH T
    Commentary on studies investigating low-dose diazoxide in hyperinsulinism.
    Clin Endocrinol (Oxf). 2024;100:138-139.
    PubMed    


  102. WALIGORA M, Smorag M, Bukala N, Zygmunt M, et al
    ECG patterns to predict pulmonary arterial hypertension in patients with severe tricuspid regurgitation.
    J Electrocardiol. 2024;82:52-58.
    PubMed    
    Abstract available

  103. LI M, Ying M, Gu S, Zhou Z, et al
    Matrine alleviates hypoxia-induced inflammation and pulmonary vascular remodelling via RPS5/NF-kappaB signalling pathway.
    J Biochem Mol Toxicol. 2024;38:e23583.
    PubMed    
    Abstract available

  104. YAVUZ YE, Soylu A, Gurbuz AS
    The relationship of systemic and pulmonary arterial parameters with HFpEF scores (H(2) FPEF, HFA-PEFF) and diastolic dysfunction parameters in heart failure patients with preserved ejection fraction.
    J Clin Ultrasound. 2024;52:39-50.
    PubMed    
    Abstract available

  105. MCLAUGHLIN V, Alsumali A, Liu R, Klok R, et al
    Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH).
    Adv Ther. 2024;41:130-151.
    PubMed    
    Abstract available

  106. PAMUKCU O, Narin N, Sunkak S, Tuncay A, et al
    Evaluation of preterm infants having bronchopulmonary dysplasia with echocardiography and serum biomarkers.
    Cardiol Young. 2024;34:137-144.
    PubMed    
    Abstract available

  107. LI R, Song M, Wang R, Su N, et al
    Can CT-Based Arterial and Venous Morphological Markers of Chronic Obstructive Pulmonary Disease Explain Pulmonary Vascular Remodeling?
    Acad Radiol. 2024;31:22-34.
    PubMed    
    Abstract available

  108. YUAN M, Hu X, Xing W, Wu X, et al
    B2M is a Biomarker Associated With Immune Infiltration In High Altitude Pulmonary Edema.
    Comb Chem High Throughput Screen. 2024;27:168-185.
    PubMed    
    Abstract available

  109. PLOEGSTRA MJ, Ivy DD, Beghetti M, Bonnet D, et al
    Long-term outcome of children with newly diagnosed pulmonary arterial hypertension: results from the global TOPP registry.
    Eur Heart J Qual Care Clin Outcomes. 2024;10:66-76.
    PubMed    
    Abstract available

  110. RILEY JM, Fradin JJ, Russ DH, Warner ED, et al
    Post-Capillary Pulmonary Hypertension: Clinical Review.
    J Clin Med. 2024;13:625.
    PubMed    
    Abstract available

  111. BAILEY M, DuBrock HM
    Pulmonary hypertension patient perspectives toward pulmonary rehabilitation.
    Pulm Circ. 2024;14:e12338.
    PubMed    
    Abstract available

  112. ANAND V, Covington MK, Saraswati U, Scott CG, et al
    Prevalence, sex differences, and implications of pulmonary hypertension in patients with apical hypertrophic cardiomyopathy.
    Front Cardiovasc Med. 2024;10:1288747.
    PubMed    
    Abstract available

  113. LEBAR K, Liu W, Pang J, Chicco A, et al
    Role of the Microtubule Network in the Passive Anisotropic Viscoelasticity of Right Ventricle with Pulmonary Hypertension Progression.
    Acta Biomater. 2024 Jan 23:S1742-7061(24)00035.
    PubMed    
    Abstract available

  114. YOU YT, Zuo H, Li JM, Zhu XB, et al
    Mediastinal Cryobiopsy for Pathological Diagnosis of Fibrosing Mediastinitis-Associated Pulmonary Hypertension.
    Respiration. 2024 Jan 25:1-5. doi: 10.1159/000535395.
    PubMed    
    Abstract available

  115. CARAVITA S, Gori M, Garascia A, Baratto C, et al
    [Pulmonary hypertension associated with left heart diseases: pathophysiology, diagnosis, treatment].
    G Ital Cardiol (Rome). 2024;25:88-97.
    PubMed    
    Abstract available

  116. SUN L, Liu L, Liang D, Liu L, et al
    SOCS5, targeted by miR-155-5p, plays a negative regulatory role in pulmonary hypertension through inhibiting JAK2/STAT3 signaling pathway.
    BMC Pulm Med. 2024;24:52.
    PubMed    
    Abstract available

  117. CAO JK, Fan HQ, Xiao YB, Wang D, et al
    [Establishment and efficiency test of a clinical prediction model of bronchopulmonary dysplasia associated pulmonary hypertension in very premature infants].
    Zhonghua Er Ke Za Zhi. 2024;62:129-137.
    PubMed    
    Abstract available

  118. MCCORMACK C, Kehoe B, Cullivan S, McCaffrey N, et al
    Safety, feasibility and effectiveness of the remotely delivered Pulmonary Hypertension and Home-Based (PHAHB) physical activity intervention.
    ERJ Open Res. 2024;10:00608-2023.
    PubMed    
    Abstract available

  119. ALBULUSHI A, Al-Saidii K, Al-Farhan H
    Impact of Tricuspid Regurgitation Severity on Mortality in Pulmonary Hypertension Patients: A Comprehensive Analysis.
    Curr Probl Cardiol. 2024 Jan 21:102405. doi: 10.1016/j.cpcardiol.2024.102405.
    PubMed    
    Abstract available

  120. PRADERE P, Le Pavec J, Bos S, Pozza A, et al
    Outcomes of listing for lung and heart-lung transplantation in pulmonary hypertension: comparative experience in France and the UK.
    ERJ Open Res. 2024;10:00521-2023.
    PubMed    
    Abstract available

  121. ZENG Y, Zhakeer G, Li B, Yu Q, et al
    A novel clinical prediction scoring system of high-altitude pulmonary hypertension.
    Front Cardiovasc Med. 2024;10:1290895.
    PubMed    
    Abstract available

  122. JASINSKA-STROSCHEIN M
    An updated review of experimental rodent models of pulmonary hypertension and left heart disease.
    Front Pharmacol. 2024;14:1308095.
    PubMed    
    Abstract available

  123. PADERVINSKIENE L, Azukaite J, Hoppenot D, Krivickiene A, et al
    The Prognostic Value of One-Year Changes in Biventricular Mechanics for Three-Year Survival in Patients with Precapillary Pulmonary Hypertension: A Cardiovascular Magnetic Resonance Feature Tracking Study.
    Medicina (Kaunas). 2024;60:141.
    PubMed    
    Abstract available

  124. ASENOV K, Dimov R, Kraeva M, Basheva-Kraeva Y, et al
    EUS-Guided Combined Injection Therapy as a Secondary Prophylaxis of Gastric Variceal Bleeding in a Patient Contraindicated for TIPS: Case Report.
    Medicina (Kaunas). 2024;60:116.
    PubMed    
    Abstract available

  125. AVERJANOVAITE V, Gumbiene L, Zeleckiene I, Sileikiene V, et al
    Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients.
    Medicina (Kaunas). 2023;60:58.
    PubMed    
    Abstract available

  126. FUKUMOTO Y
    Pathophysiology and Treatment of Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2024;25:1166.
    PubMed    
    Abstract available

  127. OKAYA T, Kawasaki T, Sato S, Koyanagi Y, et al
    Functional Roles of CD26/DPP4 in Bleomycin-Induced Pulmonary Hypertension Associated with Interstitial Lung Disease.
    Int J Mol Sci. 2024;25:748.
    PubMed    
    Abstract available

  128. LIU A, Price LC, Sharma R, Wells AU, et al
    Sarcoidosis Associated Pulmonary Hypertension.
    Biomedicines. 2024;12:177.
    PubMed    
    Abstract available

  129. MASON T, Mukherjee B, Marino P
    Pulmonary Hypertension and the Gut Microbiome.
    Biomedicines. 2024;12:169.
    PubMed    
    Abstract available

  130. SANTOS EW, Khatoon S, Di Mise A, Zheng YM, et al
    Mitochondrial Dynamics in Pulmonary Hypertension.
    Biomedicines. 2023;12:53.
    PubMed    
    Abstract available

  131. GHANI H, Pepke-Zaba J
    Chronic Thromboembolic Pulmonary Hypertension: A Review of the Multifaceted Pathobiology.
    Biomedicines. 2023;12:46.
    PubMed    
    Abstract available

  132. YANG KM, Wang MT, Tao CW, Wu YJ, et al
    The long-term outcome of chronic thromboembolic pulmonary hypertension: Pulmonary endarterectomy and balloon pulmonary angioplasty.
    J Chin Med Assoc. 2024 Jan 22. doi: 10.1097/JCMA.0000000000001059.
    PubMed    
    Abstract available

  133. HEISS J, Grun K, Singerer I, Tempel L, et al
    Expression of Inflammatory Genes in Murine Lungs in a Model of Experimental Pulmonary Hypertension: Effects of an Antibody-Based Targeted Delivery of Interleukin-9.
    Adv Respir Med. 2024;92:27-35.
    PubMed    
    Abstract available

  134. LEKANE M, Burnotte P, Gommeren K, Mc Entee K, et al
    Left ventricular eccentricity index to assess precapillary pulmonary hypertension in dogs.
    J Vet Cardiol. 2023;51:220-231.
    PubMed    
    Abstract available

  135. NUNES H, Brillet PY, Bernaudin JF, Gille T, et al
    Fibrotic Pulmonary Sarcoidosis.
    Clin Chest Med. 2024;45:199-212.
    PubMed    
    Abstract available

  136. SAVALE L, Dorfmuller P, Boucly A, Jais X, et al
    Sarcoidosis-Associated Pulmonary Hypertension.
    Clin Chest Med. 2024;45:185-197.
    PubMed    
    Abstract available

  137. KIRKIL G
    Predictors of Mortality in Sarcoidosis.
    Clin Chest Med. 2024;45:175-183.
    PubMed    
    Abstract available

  138. CHARIF F, Dakroub F, Bou Akl I, Kularatne M, et al
    Pulmonary arterial hypertension and COVID-19: Piecing the puzzle.
    Respir Med Res. 2023;84:101053.
    PubMed    
    Abstract available

  139. DING R, Sang S, Yi J, Xie H, et al
    G6PD is a prognostic biomarker correlated with immune infiltrates in lung adenocarcinoma and pulmonary arterial hypertension.
    Aging (Albany NY). 2024;16:466-492.
    PubMed    
    Abstract available

  140. AL-HOSNI R, Kaye R, Choi CS, Tammaro P, et al
    The TMEM16A channel as a potential therapeutic target in vascular disease.
    Curr Opin Nephrol Hypertens. 2024;33:161-169.
    PubMed    
    Abstract available

  141. CHE H, Yi J, Zhao X, Yu H, et al
    Characterization of PKCalpha-rutin interactions and their application as a treatment strategy for pulmonary arterial hypertension by inhibiting ferroptosis.
    Food Funct. 2024;15:779-793.
    PubMed    
    Abstract available

  142. KOSTYUNINA DS, Pakhomov NV, Jouida A, Dillon E, et al
    Transcriptomics and proteomics revealed sex differences in human pulmonary microvascular endothelial cells.
    Physiol Genomics. 2024;56:194-220.
    PubMed    
    Abstract available

  143. A X, Huayu M, Li Z, Su S, et al
    In vivo pharmacokinetic study of vanillic acid in monocrotaline-induced pulmonary arterial hypertension rats and its tissue distribution.
    Biomed Chromatogr. 2024;38:e5793.
    PubMed    
    Abstract available

  144. ERHARDSSON M, Faxen UL, Venkateshvaran A, Hage C, et al
    Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failure.
    ESC Heart Fail. 2024;11:601-605.
    PubMed    
    Abstract available

  145. KAMP JC, Neubert L, Schupp JC, Braubach P, et al
    Multilamellated Basement Membranes in the Capillary Network of Alveolar Capillary Dysplasia.
    Am J Pathol. 2024;194:180-194.
    PubMed    
    Abstract available

  146. MUHLBACHER A, Beaudet A, Brand M, Janssen EM, et al
    Patient Preferences in Pulmonary Arterial Hypertension, a Latent Class Analysis to Identify Preference Heterogeneity.
    Value Health. 2024;27:206-215.
    PubMed    
    Abstract available

  147. NABEH OA, Saud AI, Amin B, Khedr AS, et al
    A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension.
    Am J Cardiovasc Drugs. 2024;24:39-54.
    PubMed    
    Abstract available

  148. DOUGHTY ES, Norvik C, Levin A, Bodmer J, et al
    Long-Term Effect of TBX4 Germline Mutation on Pulmonary Clinico-Histopathologic Phenotype.
    Pediatr Dev Pathol. 2024;27:83-89.
    PubMed    
    Abstract available

  149. BOXHAMMER E, Dienhart C, Kletzer J, Ramsauer S, et al
    Elevated systolic pulmonary artery pressure is a substantial predictor of increased mortality after transcatheter aortic valve replacement in males, not in females.
    Clin Res Cardiol. 2024;113:138-155.
    PubMed    
    Abstract available

  150. JHA AK
    Phenotypic characterization of heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2023 Aug 10. doi: 10.1002/ejhf.2996.
    PubMed    


  151. SATHIAVAGEESAN S, Shanmugam VB, Sundaram V
    The impact of vascular access location on pulmonary arterial pressure in chronic kidney disease patients undergoing hemodialysis.
    Semin Dial. 2023 Apr 2. doi: 10.1111/sdi.13154.
    PubMed    
    Abstract available

  152. CRISPINO SP, Segreti A, La Porta Y, Liporace P, et al
    A sudden right-to-left shunt: the importance of evaluating patent foramen ovale during exercise.
    Monaldi Arch Chest Dis. 2023;94.
    PubMed    
    Abstract available

  153. CHOUDHARY R, Kumari S, Ali M, Thinlas T, et al
    Respiratory tract infection: an unfamiliar risk factor in high-altitude pulmonary edema.
    Brief Funct Genomics. 2024;23:38-45.
    PubMed    
    Abstract available

  154. GOKHALE T, Harinstein ME
    Challenging the Paradigm of Post-Capillary Pulmonary Hypertension.
    Am J Cardiol. 2023 Dec 30:S0002-9149(23)01445.
    PubMed    


  155. PATARROYO APONTE MM
    When Bad and Worse Collide: Venous Thromboembolic Disease and Pulmonary Hypertension.
    Am J Cardiol. 2024 Jan 9:S0002-9149(23)00252.
    PubMed    


  156. HANSEN TS, Karimi Galougahi K, Tang O, Tsang M, et al
    The FXYD1 protein plays a protective role against pulmonary hypertension and arterial remodelling via redox and inflammatory mechanisms.
    Am J Physiol Heart Circ Physiol. 2023 Dec 22. doi: 10.1152/ajpheart.00090.2023.
    PubMed    
    Abstract available

  157. RAJAGOPAL S, Yu YR
    Determining the Architecture of Inflammation in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2024;209:131-133.
    PubMed    


  158. FERRIAN S, Cao A, McCaffrey EF, Saito T, et al
    Single-Cell Imaging Maps Inflammatory Cell Subsets to Pulmonary Arterial Hypertension Vasculopathy.
    Am J Respir Crit Care Med. 2024;209:206-218.
    PubMed    
    Abstract available

  159. HAKIM A, Fricker ZP, Feuerstein JD, Farber HW, et al
    Recurrent Gastrointestinal Bleeding in a Patient With Pulmonary Arterial Hypertension Treated With Sotatercept.
    Ann Intern Med. 2024;177:115-117.
    PubMed    


  160. MADANI MM
    Acute Kidney Injury Post Pulmonary Thromboendarterectomy: Is It a Valid Concern? A Word of Caution.
    Ann Thorac Surg. 2024;117:318-319.
    PubMed    


  161. FRANTZ RP, Swift AJ
    Advancing Risk Stratification in Pulmonary Arterial Hypertension Through Cardiac MRI: The Need for Collaboration and Standardization.
    Chest. 2024;165:12-13.
    PubMed    


  162. CELANT LR, Wessels JN, Marcus JT, Meijboom LJ, et al
    Toward the Implementation of Optimal Cardiac Magnetic Resonance Risk Stratification in Pulmonary Arterial Hypertension.
    Chest. 2024;165:181-191.
    PubMed    
    Abstract available

  163. BIAN JS, Chen J, Zhang J, Tan J, et al
    ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.
    Circulation. 2024 Jan 12. doi: 10.1161/CIRCULATIONAHA.123.067005.
    PubMed    
    Abstract available

  164. NASROLLAHIZADEH A, Soleimani H, Nasrollahizadeh A, Hashemi SM, et al
    Navigating the Sotatercept landscape: A meta-analysis of clinical outcomes.
    Clin Cardiol. 2024;47:e24173.
    PubMed    
    Abstract available

  165. TAMURA Y, Tamura Y, Shigeta A, Hosokawa K, et al
    Adult-onset idiopathic peripheral pulmonary artery stenosis.
    Eur Respir J. 2023;62:2300763.
    PubMed    
    Abstract available

  166. HAFNER F, Kindt A, Strobl K, Forster K, et al
    MRI pulmonary artery flow detects lung vascular pathology in preterms with lung disease.
    Eur Respir J. 2023 Sep 7:2202445. doi: 10.1183/13993003.02445-2022.
    PubMed    
    Abstract available

  167. PLUNKETT MJ, Sayegh ALC, McWilliams TJ, Sithamparanathan S, et al
    The skeletal muscle metaboreflex: a novel driver of ventilation, dyspnoea and pulmonary haemodynamics during exercise in pulmonary arterial hypertension.
    Eur Respir J. 2024;63:2300952.
    PubMed    
    Abstract available

  168. WESSELS JN, Bogaard HJ
    Double Down on Single-Tablet Combination Therapy in Pulmonary Arterial Hypertension: Possible Benefits for Selected Patients.
    J Am Coll Cardiol. 2024;83:485-487.
    PubMed    


  169. GRUNIG E, Jansa P, Fan F, Hauser JA, et al
    Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2024;83:473-484.
    PubMed    
    Abstract available

  170. BRUCE MR, Frasco PE, Sell-Dottin KA, Cuevas CV, et al
    Days Alive and Out of the Hospital After Heart Transplantation: A Retrospective Cohort Study.
    J Cardiothorac Vasc Anesth. 2024;38:93-100.
    PubMed    
    Abstract available

  171. ATEFIPOUR N, Dianat M, Badavi M, Radan M, et al
    The Role of Rosmarinic Acid in the Protection against Inflammatory Factors in Rats Model with Monocrotaline-Induced Pulmonary Hypertension: Investigating the Signaling Pathway of NFkappaB, OPG, Runx2, and P-selectin in Heart.
    J Cardiovasc Pharmacol. 2023 Dec 26. doi: 10.1097/FJC.0000000000001534.
    PubMed    
    Abstract available

  172. LI J, He X, Liu F, Zheng X, et al
    Tumor Necrosis Factor-alpha-Induced Protein-8-like 2 Transfected Adipose-Derived Stem Cells Regulated the Dysfunction of Monocrotaline Pyrrole-Induced Pulmonary Arterial Smooth Muscle Cells and Pulmonary Arterial Endothelial Cells.
    J Cardiovasc Pharmacol. 2024;83:73-85.
    PubMed    
    Abstract available

  173. JANOWSKI AM, Ravellette KS, Insel M, Garcia JG, et al
    Advanced Hemodynamic and Cluster Analysis for Identifying Novel RV function subphenotypes in Patients with Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02178.
    PubMed    
    Abstract available

  174. CRUZ-UTRILLA A, Lopez-Gude MJ, Velazquez M, Ynsaurriaga FA, et al
    Comment on the article titled "Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension" published by J. Chan et al.
    J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02177.
    PubMed    


  175. PARIKH R, Farber HW
    Response to "Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD" by Nathan et al.
    J Heart Lung Transplant. 2023 Dec 27:S1053-2498(23)02199.
    PubMed    


  176. GHIO S, Corsico A, Rapagnani A, Borrelli E, et al
    Does pulmonary endarterectomy improve the clinical conditions of patients with chronic thromboembolic pulmonary disease without pulmonary hypertension?
    J Heart Lung Transplant. 2024 Jan 4:S1053-2498(23)02203.
    PubMed    
    Abstract available

  177. MCLAUGHLIN V, Farber HW, Highland KB, Hemnes AR, et al
    Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry).
    J Heart Lung Transplant. 2024;43:272-283.
    PubMed    
    Abstract available

  178. CHIA AXF, Valchanov K, Ng C, Tsui S, et al
    Perioperative extracorporeal membrane oxygenation support for pulmonary endarterectomy: A 17-year experience from the UK national cohort.
    J Heart Lung Transplant. 2024;43:241-250.
    PubMed    
    Abstract available

  179. HAYASHI H, Ning Y, Kurlansky P, Vaynrub A, et al
    Characteristics and prognostic significance of right heart remodeling and tricuspid regurgitation after pulmonary endarterectomy.
    J Thorac Cardiovasc Surg. 2022 Apr 8. pii: S0022-5223(22)00391.
    PubMed    
    Abstract available

  180. SAKARIN S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, et al
    Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
    PLoS One. 2024;19:e0296068.
    PubMed    
    Abstract available

  181. LIU H, Pan Z, Wu X, Gong C, et al
    Jagged 2 inhibition attenuates hypoxia-induced mitochondrial damage and pulmonary hypertension through Sirtuin 1 signaling.
    PLoS One. 2024;19:e0297525.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.


;